Optimizing Stimulation Parameters for Electroconvulsive Therapy
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- University of Pennsylvania
- Study ID
- NCT07561307
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Catatonia
- Depression - Major Depressive Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electroconvulsive Therapy — PROCEDUREElectrical stimulation under anesthesia
Study Details
The goal of this clinical trial is to improve how electroconvulsive therapy (ECT) stimulation settings are chosen. Researchers will use real-time brain monitoring to measure both seizures and a recently identified brain event called cortical spreading depolarization (CSD). The main questions it aims to answer are: What is the best way to increase ECT stimulation settings? How do different pulse settings affect the brain's response? Can certain settings produce CSD without causing a seizure? Participants already receiving ECT as part of their care will take part. They will be assigned to one of two groups: Index ECT group: Participants starting ECT will receive different standard titration approaches. Maintenance ECT group: Participants receiving ongoing ECT will undergo a brief, low-dose stimulation test before treatment. All participants will be monitored using brain physiology (EEG and blood flow) and symptom scales during treatment.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2029
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 64 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Index: Standard titration tablePatients are treated with ECT using titration table 1 (alternating increases in frequency and duration)
- Experimental: Index: Frequency-then-durationECT provided using Table 2, frequency uptitration followed by duration uptitration
- Experimental: Index: Duration then FrequencyECT provided using Table 3, duration titration then frequency titration
- Other: MaintenanceInternal cross-over arm in which patients undergo 8 sessions using 8 randomized sub-convulsive stimulation protocols
Primary Outcome Measure
Brain hemodynamics [ Time Frame: Periprocedural (10-20 minutes per ECT session). Assessed repeatedly over approximately 12 ECT sessions for index arm patients (3 times/week for 4-6 weeks), or for 8 sessions (once a month for 8 months) in the maintenance arm. ]
Central Contacts
- Zachary Rosenthal, MD PhD19738976511
- Mario Cristancho, MD
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pennsylvania Hospital | Philadelphia | Pennsylvania | 19146 |
Find similar trials in Philadelphia, PA
Related Studies
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPHASE3 · Recruiting · Cybin IRL Limited · Birmingham, Alabama
- An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.Not Yet Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkSRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Open-Label Psilocybin Study in Transdiagnostic PopulationPHASE1 · Recruiting · Yale University · New Haven, Connecticut